TREATMENT OF DEGENERATIVE VASCULAR DISEASES THROUGH MODULATION OF THE PRODUCTION OR ACTIVITY OF EXOGENOUS NITRICAL OXIDE.

摘要

ATEROGENESIS AND RESTENOSIS ARE TREATED THROUGH LONG-TERM ADMINISTRATION OF PHYSIOLOGICALLY ACCEPTABLE COMPOUNDS THAT INCREASE THE LEVEL OF ENDOGENOUS NITRICAL OXIDE AND OTHER INTERMEDIARIES IN THE INJURY RELAXED TRAJECTORY. ALTERNATIVELY, OR IN COMBINATION, OTHER COMPOUNDS THAT PROVIDE SHORT IMPROVEMENT OF NITRIC OXIDE, WELL DIRECTLY OR THROUGH PHYSIOLOGICAL PROCESSES, CAN BE ADMINISTERED. IN ADDITION, THE CELLS CAN BE TREATED BY GENETIC ENGINEERING TO PROVIDE A COMPONENT IN THE SYNTHETIC TRAJECTORY TO NITRIC OXIDE, TO PERFORM THE PROCESS OF IMPROVING THE CONCENTRATION OF NITRIC OXIDE, PARTICULARLY TOGETHER OF AN ADMINISTRATION.